Tamás Bűdi

发表

Relevance of CYP2C9 Function in Valproate Therapy

G. Csukly, K. Monostory, M. Déri, 2018, Current neuropharmacology.

Phenoconversion of CYP 2 C 9 in epilepsy limits the predictive value of 2 CYP 2 C 9 genotype in optimizing valproate therapy 3 4

K. Monostory, K. Tóth, Adam Kiss, 2015 .

Phenoconversion of CYP2C9 in epilepsy limits the predictive value of CYP2C9 genotype in optimizing valproate therapy.

K. Monostory, K. Tóth, Adam Kiss, 2015, Personalized medicine.

Clinical significance of CYP2C9‐status guided valproic acid therapy in children

M. Garami, K. Monostory, K. Tóth, 2015, Epilepsia.

In response: Commentary on clinical significance of CYP2C9‐status‐guided valproic acid therapy in children

M. Garami, K. Monostory, K. Tóth, 2016, Epilepsia.

Association between CYP2B6 genetic variability and cyclophosphamide therapy in pediatric patients with neuroblastoma

M. Garami, K. Monostory, T. Micsik, 2023, Scientific reports.